Nancy D. Ebelt
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 13
- Cancer Cells and Metastasis 4
- Cancer-related Molecular Pathways 4
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer Research and Treatments 5
- Co-authors
- Edwin Ramos Manuel (12 shared papers)Monica Marzagalli (2 shared papers)Carla L. Van Den Berg (6 shared papers)M. A. Cantrell (1 shared paper)Blerta Xhemalçe (1 shared paper)Travis H. Stracker (1 shared paper)Kyle M. Miller (1 shared paper)Tamer Saad Kaoud (3 shared papers)
- Journals
- Oncotarget (3 papers)Cancers (3 papers)Nature Communications (2 papers)Molecular Medicine (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesEgyptSpain
In The Last Decade
Nancy D. Ebelt
20 papers receiving 843 citations
Peers
Comparison fields: 5 of 84
- Oncology 308
- Immunology 199
- Biotechnology 67
- Cancer Research 79
- Cell Biology 92
Countries citing papers authored by Nancy D. Ebelt
This map shows the geographic impact of Nancy D. Ebelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy D. Ebelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy D. Ebelt more than expected).
Fields of papers citing papers by Nancy D. Ebelt
This network shows the impact of papers produced by Nancy D. Ebelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy D. Ebelt. The network helps show where Nancy D. Ebelt may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy D. Ebelt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 285 | |
| 2 | 2020 | 83 | |
| 3 | 2015 | 66 | |
| 4 | 2013 | 56 | |
| 5 | 2016 | 55 | |
| 6 | 2019 | 51 | |
| 7 | 2010 | 41 | |
| 8 | 2017 | 34 | |
| 9 | 2017 | 26 | |
| 10 | 2019 | 26 | |
| 11 | 2021 | 25 | |
| 12 | 2020 | 23 | |
| 13 | 2009 | 23 | |
| 14 | 2020 | 20 | |
| 15 | 2020 | 19 | |
| 16 | 2015 | 8 | |
| 17 | 2024 | 7 | |
| 18 | 2017 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2022 | 2 |
About Nancy D. Ebelt
Nancy D. Ebelt is a scholar working on Oncology, Biotechnology, Molecular Biology, Immunology and Allergy and Immunology, having authored 21 papers that have together received 863 indexed citations. Recurring topics across this work include Cancer Research and Treatments (5 papers), Cancer Cells and Metastasis (4 papers), Cancer-related Molecular Pathways (4 papers), Melanoma and MAPK Pathways (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Oncology (308 citations), Immunology (199 citations), Biotechnology (67 citations), Cancer Research (79 citations) and Cell Biology (92 citations). Nancy D. Ebelt has collaborated with scholars based in United States, Egypt and Spain. Frequent co-authors include Edwin Ramos Manuel, Monica Marzagalli, Carla L. Van Den Berg, M. A. Cantrell, Blerta Xhemalçe, Travis H. Stracker, Kyle M. Miller, Tamer Saad Kaoud, Kevin N. Dalby and Don J. Diamond. Their work appears in journals such as Oncotarget, Cancers, Nature Communications, Molecular Medicine and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.